Abstract
To delineate the biochemical sequences of myelination in the human brain, we analyzed the protein and lipid composition of white matter in 18 baseline cases ranging in age from midgestation through infancy, the critical period in human myelination when the most rapid changes occur. Three adult cases were used as indices of maturity, and 4 cases with major disorders of CNS myelination (maple syrup urine disease, severe periventricular leukomalacia, idiopathic central hypomyelination, and metachromatic leukodystrophy) were analyzed. Brain samples were obtained ≤24 hours after death. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high performance thinlayer chromatography were used to separate and identify proteins and polar and neutral lipids in an average of 10 sites/brain; computer-based densitometry was used to quantify polar lipids. Biochemical sequences, as manifested by the appearance of the myelin-associated lipids and myelin-specific proteins, closely followed previously described anatomic sequences both temporally and by region, and were identical in all sites sampled: sphingomyelin was followed simultaneously by cerebrosides, MBP, PLP, and nonhydroxy-sulfatide, followed by hydroxy-sulfatide. The onset and tempo of the expression of individual constituents, however, were quite variable among sites, suggesting a wide differential in vulnerable periods to insult in biochemically-specific pathways in early life. Cholesterol ester was transiently elevated during late gestation and early infancy, prior to and around the time of the appearance of cerebrosides, sulfatides, PLP, and MBP. Distinctive lipid and protein abnormalities were detected in idiopathic central hypomyelination and metachromatic leukodystrophy. This study underscores the feasibility of the combined biochemical approaches in pediatric brains and provides guidelines for the assessment of disorders of myelination in early human life.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brody, B. A., Kinney, H. C., Kloman, A., and Gilles, F. H. 1987. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J. Neuropathol. Exp. Neurol. 46:283–301.
Kinney, H. C., Brody, B. A., Kloman, A., and Gilles, F. H. 1988. Sequence of central system myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropathol. Exp. Neurol. 47:217–234.
Flechsig, P. E. 1920. Anatomic des Menschlichen Gehirns und Ruckenmarks auf Myelogenetischer Gundlange. Volume 1. Leipzig: Thieme.
Yakovlev, P. I., and Lecours, A. R. 1967. The myelogenetic cycles of regional maturation of the brain. Pages 3–70,in Minkowski, A. (ed.), Regional development of the brain in early life, Oxford, Blackwell.
Keene, M. F. L., and Hewer, E. E. 1931. Some observations on myelination in the human central nervous system. J. Anat. 66:1–13.
Langworthy, O. R. 1933. Development of behavior patterns and myelinization of the nervous system in the human fetus and infant. Pages 1–57,in Contributions to embryology. Volume XXVI, Carnegie Institute of Washington, Washington, D.C.
Rorke, L. B., and Riggs, H. E. 1969. Myelination of the brain in the newborn. Lippincott, Philadelphia.
Richardson, E. P. 1982. Myelination in the human central nervous system. Pages 146–173,in Haymaker, W., and Adams, R. D. (eds.), Histology and histopathology of the nervous system, Thomas, Springfield.
Gilles, F. H., Leviton, A., and Dooling, E. C. 1983. The Developing Human Brain: growth and Epidemiologic Neuropathology. John Wright-PSG, Inc., Boston.
Weidenheim, K. M., Kress, Y., Ipshteyn, I., Rashbaum, W. K., and Lyman, W. D. 1992. Early myelination in the human fetal lumbosacral spinal cord: Characterization by light and electron microscopy. J. Neuropath. Exp. Neurol. 51:142–149.
Choi, B. 1981. Radial glial of the developing human fetal spinal cord: Golgi, immunohistochemical and electron microscopic study. Dev. Brain 1:249–267.
Deber, C. M., and Reynolds, S. J. 1991. Central nervous system myelin: structure, function, and pathology. Clin. Biochem. 24:113–134.
Lees, M. B., and Brostoff, S. W. 1984. Proteins of myelin. Pages 197–217,in Morell, P. (ed.), Myelin, Plenum Press, New York.
Fishman, M. A., Agrawal, H. C., Alexander, A., Golterman, J., Matenson, R. E., and Mitchell, R. F. 1975. Biochemical maturation of human central nervous system myelin. J. Neurochem. 24:689–695.
Poduslo, S. E., and Jang, Y. 1984. Myelin development in infant brain. Neurochem. Res. 9:1615–1626.
Niebroj-Dobosz, I., Fidzianska, A., Rafalowska, J., and Sawicka, E. 1980. Correlative biochemical and morphologic studies of myelination in human ontogenesis. I. Myelination of the spinal cord. Acta Neuropathol. (Berl.) 49:145–152.
Savolainen, H., Palo, J., Riekkinen, P., Moronen, P., and Brady, L. E. 1972. Maturation of myelin proteins in human brain. Brain Res. 37:253–263.
Conde, C., Martinez, M., and Ballabriga,A. 1974. Some chemical aspects of brain development. I. Neutral glycosphingolipids, sulfatides, and sphingomyelin. Pediatr. Res. 8:89–92.
Martinez, M. 1982. Myelin lipids in the developing cerebrum, cerebellum, and brain stem of normal and undernourished children. J. Neurochem. 39:1684–1692.
Svennerholm, L., Vanier, M. T., and Jungbjer, B. 1978. Changes in fatty acid composition of human brain myelin lipids during maturation. J. Neurochem. 30:1383–1390.
Kronquist, K. E., Crandall, B. F., Macklin, W. B., and Campagnoni, A. T. 1987. Expression of myelin proteins in the developing human spinal cord: cloning and sequencing of human proteolipid protein cDNA. J. Neurosci. Res. 18:394–401.
Kamholz, J., Toffenetti, J., and Lazzarini, R. A. 1988. Organization and expression of the human myelin basic protein gene. J. Neurosci. Res. 21:62–70.
Eng, L. F., Chao, F. C., Gerstl, B., Pratt, D., and Tavastijevna, M. G. 1986. The maturation of human white matter myelin. Fractionation of the myelin proteins. Biochemistry 7:4455–4465.
Alling, C., and Svennerholm, L. 1973. Concentration and fatty acid composition of cholesteryl esters of normal human brain. J. Neurochem. 20:1589–1603.
Cummings, J. N., Goodwin, H., Woodward, E. M., and Curzon, G. 1958. Lipids in the brain of infants and children. J. Neurochem. 2:289–294.
Clausen, J., Cristensen Lour, H. O., and Andersen, H. 1965. Phospholipid and glycolipid patterns of infant and foetal brain. Thin-layer chromatographic studies. J. Neurochem. 12:599–606.
Svennerholm, L. 1964. The distribution of lipids in the human nervous system. I. Analytical procedure. Lipids of foetal and new-born brain. J. Neurochem. 11:839–853.
Svennerholm, L., and Vanier, M. T. 1972. The distribution of lipids in the human nervous system. II. Lipid composition of human foetal and infant brain. Brain Res. 47:457–468.
Silberman, J., Dancis, J., and Feigin, I. 1961. Neuropathological observations in maple syrup urine disease; branched-chain ketoaciduria. Arch. Neurol. 5:351–363.
Prensky, A. L., Carr, S., and Moser, H. W. 1968. Development of myelin in inherited disorders of amino acid metabolism. A biochemical investigation. Arch. Neurol. 19:552–558.
Rorke, L. B. 1992. Perinatal brain damage. Pages 639–708,in Greenfield's Neuropathology, Adams, J. H., and Duchen, L. W. (eds.), Oxford University Press, New York.
Armstrong, D., and Norman, M. G. 1974. Periventricular leukomalacia in neonates. Complications and sequelae. Arch. Dis. Child. 49:367–375.
Banker, B. Q., and Larrouche, J.-C. 1964. Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch. Neurol. 7:386–410.
de Vries, L. S., Wigglesworth, J. S., Regev, R., and Dubowitz, L. M. S. 1988. Evaluation of periventricular leukomalacia during the neonatal period and infancy: correlation of imaging and postmortem findings. Early Hum. Dev. 17:205–219.
Dambska, M., Laure-kamionowska, M., and Schmidt-Sidor, B. 1989. Early and late neuropathological changes in perinatal white matter damage. J. Child. Neurol. 4:291–298.
Paneth, N., Rudelli, R., Monte, W., Rodriguez, E., Pinto, J., Kairam, R., and Kazam, E. 1990. White matter necrosis in very low birth weight infants: neuropathologic and ultrasonographic findings in infants surviving six days or longer. J. Pediatr. 116:975–984.
Leviton, A., and Gilles, F. H. 1984. Acquired perinatal leukoencephalopathy. Ann. Neurol. 16:1–8.
Haberland, C., Brunngraber, E., Witting, L., et al., 1973. Juvenile metachromatic leukodystrophy: case report with clinical, histopathological, ultrastructural and biochemical observations. Acta Neuropathol. (Berl.) 26:93–106.
Suzuki, K., Suzuki, K., and Chin, G. C. 1967. Isolation and clinical characterization of metachromatic granules from a brain with metachromatic leukodystrophy. J. Neuropathol. Exp. Neurol. 26:537–550.
Poduslo, S. E., Miller, K., and Jang, Y. 1982. Biochemical studies of the late infantile form of metachromatic leukodystrophy. Acta Neuropathol. (Berl.) 57:13–22.
Polten, A., et al. 1991. Molecular basis of different forms of metachromatic leukodystrophy. N. Eng. J. Med. 324:18–22.
Kolodny, E. 1989. Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. Pages 1721–1750,in Shriver, C. R., et al. (eds.), The Metabolic Basis of Inherited Disease, McGraw Hill, New York.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Maizel, J. V. 1971. Polyacrylamide gel electrophoresis of viral proteins. Methods Virol. 5:179–246.
Kirschner, D. A., Inouye, H., Ganser, A. L., and Mann, V. 1989. Myelin membrane structure and composition correlated: a phylogenetic study. J. Neurochem. 53:1599–1609.
Ganser, A. L., Kerner, A-L., Brown, B. J., Davisson, M. T., and Kirschner, D. A. 1988. A survey of neurological mutant mice I. Lipid composition of myelinated tissue in known myelin mutants. Dev. Neurosci. 10:99–122.
Towbin, H., Staehlin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyarcrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. 76:4350–4354.
Warriington, A. E., and Pfeiffer, S. E. 1992. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies. J. Neurosci. Res. 33:338–353.
Bansal, R., Warrington, A. E., Gard, A. L., Ranscht, B., and Pfeiffer, S. E. 1989. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:548–557.
Hardy, R., and Reynolds, R. 1991. Proliferation and differentiation of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111:1061–1080.
Wender, M., Adamczewska-Goncerzewicz, Z., Szczech, J., and Godlewsik, A., 1988. Myelin lipids in aging human brain. Neurochem. Pathol. 8:121–130.
Riederer, B., Honegger, C., Tobler, H., Ulrich, J. The effect of age on the microheterogeneous pattern of human myelin basic protein. Gerontology 30:234–239.
Soderberg, M., Edlund, C., Kristensson, K., and Dallner, G. 1990. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54:415–423.
Amur-Umarjee, S. G., Dasu, R. G., and Campagnoni, A. T. 1990. Temporal expression of myelin-specific components in neonatal mouse brain cultures: Evidence that 2′3′-cyclic nucleotide 3′-phosphodiesterase appears prior to galactocerebroside. Dev. Neurosci. 12:251–62.
Knapp, P. E., Skoff, R. P., and Sprinkle, T. J. 1988. Differential expression of galactocerebroside, myelin basic protein, and 2′3′-cyclic nucleotide 3′-phosphodiesterase during development of oligodendrocytes in vitro. J. Neurosci. Res. 21:249–59.
Langan, T. J., and Volpe, J. J., 1986. Obligatory relationship between the sterol biosynthetic pathway and DNA synthesis and cellular proliferation in ghal primary cultures. J. Neurochem. 46:1283–91.
Eto, Y., and Suzuki, K. 1972. Cholesterol esters in developing rat brain: Enzymes of cholesterol ester metabolism. J. Neurochem. 19:117–121.
Jagannatha, H. M., and Sastry, P. S. 1981. Cholesterol-esterifying enzymes in developing rat brain. J. Neurochem. 36:1352–1360.
Friede, R. L. 1989. Developmental Neuropathology. Springer-Verlag, Berlin: 69–81.
Mickel, H. S., and Gilles, F. H. 1970. Changes in glial cells during human telencephalic myeliogenesis. Brain 93:337–46.
Jellinger, K., Seitelberger, F., and Kozik, M. 1971. Perivascular accumulation of lipids in the infant human brain. Acta Neuropathol. (Berl.) 19:331–42.
Leech, R. W., and Alvord, E. C. 1974. Glial fatty metamorphosis. An abnormal response of premyelin glia frequently accompanying periventricular leukomalacia. Am. J. Pathol. 74:603–612.
Sumi, S. M., Leech, R. W., Alvord, E. C., Eng, M. and Niland, K. 1973. Sudanophilic lipids in the unmyelinated primate cerebral white matter following intrauterine hypoxia and acidosis. Assoc. Res. Nerv. Ment. Dis. 51:176–197.
Larroche, J. C., and Amawaka, H. 1973. Glia of myelination and fat deposit during early myelogenesis. Biol. Neonate 22:421–435.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Marjorie B. Lees.
Rights and permissions
About this article
Cite this article
Kinney, H.C., Karthigasan, J., Borenshteyn, N.I. et al. Myelination in the developing human brain: Biochemical correlates. Neurochem Res 19, 983–996 (1994). https://doi.org/10.1007/BF00968708
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00968708